Claudia Riedl
Förmögenhet: 1 249 $ per 2026-09-30
Förmögenhet: 1 249 $ per 2026-09-30
Dr. Claudia Riedl is an Independent Non-Executive Director at Vivoryon Therapeutics NV.
She is on the Board of Directors at Vivoryon Therapeutics NV.
Dr. Riedl was previously employed as a Head-Corporate Communications & Investor Relations by MorphoSys AG.
She received her doctorate degree from Technische Universität München.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-06-30 | 1 000 ( 0 % ) | 1 249 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Direktör/Styrelseledamot | 2022-01-01 |
| Företag | Position | Slut |
|---|---|---|
| MORPHOSYS AG | Offentlig kommunikationskontakt | 2016-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Technische Universität München
Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån